Yamasaki A - Search Results

1

Multiseptate gallbladder: report of a case.

Yamasaki A, Chijiiwa K, Jimi S, Hotokezaka M, Asada T, Etoh T, Naganuma S, Yamaguchi K. Yamasaki A, et al. Hepatogastroenterology. 2008 May-Jun;55(84):859-60. Hepatogastroenterology. 2008. PMID: 18705283

2

Asymptomatic adenocarcinoma arising from a gastric duplication cyst: A case report.

Yamasaki A, Onishi H, Yamamoto H, Ienaga J, Nakafusa Y, Terasaka R, Nakamura M. Yamasaki A, et al. Int J Surg Case Rep. 2016;25:16-20. doi: 10.1016/j.ijscr.2016.05.055. Epub 2016 Jun 2. Int J Surg Case Rep. 2016. PMID: 27289170 Free PMC article.

3

Hypoxia and pancreatic ductal adenocarcinoma.

Yamasaki A, Yanai K, Onishi H. Yamasaki A, et al. Cancer Lett. 2020 Aug 1;484:9-15. doi: 10.1016/j.canlet.2020.04.018. Epub 2020 May 5. Cancer Lett. 2020. PMID: 32380129 Review.

4

Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ERalpha-positive gastric cancer.

Kameda C, Nakamura M, Tanaka H, Yamasaki A, Kubo M, Tanaka M, Onishi H, Katano M. Kameda C, et al. Among authors: yamasaki a. Br J Cancer. 2010 Feb 16;102(4):738-47. doi: 10.1038/sj.bjc.6605517. Epub 2010 Jan 19. Br J Cancer. 2010. PMID: 20087349 Free PMC article.

5

Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway.

Ikebe M, Kitaura Y, Nakamura M, Tanaka H, Yamasaki A, Nagai S, Wada J, Yanai K, Koga K, Sato N, Kubo M, Tanaka M, Onishi H, Katano M. Ikebe M, et al. Among authors: yamasaki a. J Surg Oncol. 2009 Dec 15;100(8):725-31. doi: 10.1002/jso.21392. J Surg Oncol. 2009. PMID: 19722233

6

Induction of cytotoxic T lymphocytes by CEA peptide-pulsed γδ T-cells isolated from patients with advanced cancer.

Yamasaki A, Onishi H, Morisaki T, Katano M. Yamasaki A, et al. Anticancer Res. 2011 Jul;31(7):2419-24. Anticancer Res. 2011. PMID: 21873153

7

Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer.

Onishi H, Yamasaki A, Kawamoto M, Imaizumi A, Katano M. Onishi H, et al. Among authors: yamasaki a. Cancer Lett. 2016 Feb 28;371(2):143-50. doi: 10.1016/j.canlet.2015.11.012. Epub 2015 Nov 30. Cancer Lett. 2016. PMID: 26655998

8

Kawamoto M, Onishi H, Ozono K, Yamasaki A, Imaizumi A, Kamakura S, Nakano K, Oda Y, Sumimoto H, Nakamura M. Kawamoto M, et al. Among authors: yamasaki a. Oncotarget. 2017 May 30;8(22):36211-36224. doi: 10.18632/oncotarget.16063. Oncotarget. 2017. PMID: 28423707 Free PMC article.

9

Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review).

Onishi H, Nakamura K, Yanai K, Nagai S, Nakayama K, Oyama Y, Fujimura A, Ozono K, Yamasaki A. Onishi H, et al. Among authors: yamasaki a. Oncol Rep. 2022 May;47(5):93. doi: 10.3892/or.2022.8304. Epub 2022 Mar 22. Oncol Rep. 2022. PMID: 35315500 Review.

10

The Novel Selective Pan-TRK Inhibitor ONO-7579 Exhibits Antitumor Efficacy Against Human Gallbladder Cancer In Vitro.

Kawamoto M, Ozono K, Oyama Y, Yamasaki A, Oda Y, Onishi H. Kawamoto M, et al. Among authors: yamasaki a. Anticancer Res. 2018 Apr;38(4):1979-1986. doi: 10.21873/anticanres.12435. Anticancer Res. 2018. PMID: 29599313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters